Evidence map›Paper›PMID 25567989›Full record

ArticleGenetics2015

Conversion of the LIN-1 ETS protein of Caenorhabditis elegans from a SUMOylated transcriptional repressor to a phosphorylated transcriptional activator.

Elizabeth R Leight, John T Murphy, Douglas A Fantz, Danielle Pepin, Daniel L Schneider, Thomas M Ratliff, Duaa H Mohammad, Michael A Herman, Kerry Kornfeld

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Outstanding questions in developmental ERK signaling.Development (Cambridge, England) · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. SUMO wrestling with Ras.Small GTPases · 2016
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Elizabeth R LeightDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri 63110.
John T MurphyDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri 63110.
Douglas A FantzDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri 63110.
Danielle PepinDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri 63110.
Daniel L SchneiderDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri 63110.
Thomas M RatliffDivision of Biology, Kansas State University, Manhattan, Kansas 66506.
Duaa H MohammadDivision of Biology, Kansas State University, Manhattan, Kansas 66506.
Michael A HermanDivision of Biology, Kansas State University, Manhattan, Kansas 66506.
Kerry KornfeldDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri 63110 kornfeld@wustl.edu.
Washington University in St. Louis · USKansas State University · US

Funding

TRANSCRIPTIONAL REGULATION OF ZINC HOMEOSTASISR01GM068598 · NIGMS · WASHINGTON UNIVERSITY · PI KORNFELD, KERRY · 2003 to 2025
$5.3M
MAP KINASE REGULATION OF SUBSTRATE PROTEINSR01CA084271 · NCI · WASHINGTON UNIVERSITY · PI KORNFELD, KERRY · 2000 to 2010
$2.6M
Investigation of LIN-1 and its inhibitor MPK-1F32GM066605 · NIGMS · WASHINGTON UNIVERSITY · PI LEIGHT, ELIZABETH R · 2002 to 2004
$109k
NCI NIH HHS CA84271NCI NIH HHS R01 CA084271NIGMS NIH HHS F32 GM066605NIGMS NIH HHS F32 GM66605NIGMS NIH HHS GM068598NIGMS NIH HHS R01 GM068598
6 · The paper itself

Abstract

The LIN-1 ETS transcription factor plays a pivotal role in controlling cell fate decisions during development of the Caenorhabditis elegans vulva. Prior to activation of the RTK/Ras/ERK-signaling pathway, LIN-1 functions as a SUMOylated transcriptional repressor that inhibits vulval cell fate. Here we demonstrate using the yeast two-hybrid system that SUMOylation of LIN-1 mediates interactions with a protein predicted to be involved in transcriptional repression: the RAD-26 Mi-2β/CHD4 component of the nucleosome remodeling and histone deacetylation (NuRD) transcriptional repression complex. Genetic studies indicated that rad-26 functions to inhibit vulval cell fates in worms. Using the yeast two-hybrid system, we showed that the EGL-27/MTA1 component of the NuRD complex binds the carboxy-terminus of LIN-1 independently of LIN-1 SUMOylation. EGL-27 also binds UBC-9, an enzyme involved in SUMOylation, and MEP-1, a zinc-finger protein previously shown to bind LIN-1. Genetic studies indicate that egl-27 inhibits vulval cell fates in worms. These results suggest that LIN-1 recruits multiple proteins that repress transcription via both the SUMOylated amino-terminus and the unSUMOylated carboxy-terminus. Assays in cultured cells showed that the carboxy-terminus of LIN-1 was converted to a potent transcriptional activator in response to active ERK. We propose a model in which LIN-1 recruits multiple transcriptional repressors to inhibit the 1° vulval cell fate, and phosphorylation by ERK converts LIN-1 to a transcriptional activator that promotes the 1° vulval cell fate.

Indexed as

Gene Expression RegulationAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsExtracellular Signal-Regulated MAP KinasesFemaleMi-2 Nucleosome Remodeling and Deacetylase ComplexPhosphorylationRepressor ProteinsSumoylationTrans-ActivatorsTranscription FactorsTwo-Hybrid System TechniquesUbiquitin-Conjugating EnzymesUbiquitin-Conjugating Enzyme UBC9VulvaCaenorhabditis elegans ProteinsExtracellular Signal-Regulated MAP KinasesLin-1 protein, C elegansMi-2 Nucleosome Remodeling and Deacetylase ComplexRepressor ProteinsTrans-ActivatorsTranscription FactorsUbiquitin-Conjugating EnzymesUbiquitin-Conjugating Enzyme UBC9chromatinETSLIN-1SUMOtranscriptionvulval development

Identifiers

PMID25567989
PMCPMC4349070
OpenAlexW2052650707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.